• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Richard Gitomer, MD, MBA

Latest:

Advancing Team-Based Primary Care: The Importance and Challenges in 2023

This editorial describes several key lessons about the development of effective value-based care delivery.


Sarah Parvanta, PhD

Latest:

Medicare Expenditures in the First Year of Amyotrophic Lateral Sclerosis Diagnosis

Medicare expenditures for patients with amyotrophic lateral sclerosis are more than 3 times those of the average Medicare beneficiary, and drug therapies are an important cost driver.


Margaret Krackeler, MD

Latest:

The Value of Real-World Data in CLL: Margaret Krackeler, MD

Margaret Krackeler, MD, of Kaiser Permanente Northern California, discusses the growing role of real-world treatment data in CLL and other cancers.


Debbie Liang, PharmD, BCCCP

Latest:

Telehealth Intervention by Pharmacists Collaboratively Enhances Hypertension Management and Outcomes

Patient interaction and enhanced support with clinical pharmacists significantly improved pass rates for a measure of controlling blood pressure compared with usual care.


Navaira Shoaib, MBBS

Latest:

GLP-1 Receptor Agonists: Trend, Necessity, or Blessing?

Glucagon-like peptide 1 (GLP-1) receptor agonists offer promise in weight and cardiovascular risk reduction, but their use must complement—not replace—lifestyle interventions within a holistic, patient-centered care model.


Harrison Greene, MD

Latest:

Influence of Prior Authorization Requirements on Provider Clinical Decision-Making

An online survey identified that documentation requirements and communication issues with health plans are associated with providers modifying clinical decisions to avoid medication prior authorization.


Roman Fabbricatore

Latest:

Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL

The glofitamab-based regimen displayed manageable safety, with minimal high-grade CRS and infrequent low-grade ICANS, in relapsed/refractory LBCL.


Ahmet Aydın, MD

Latest:

Risk Assessments of Drug-Related Problems for Cardiac Surgery Patients

Risk assessments of drug-related problems for cardiac surgery patients can be conducted by implementing a framework for patient safety.



Tod Mijanovich, PhD

Latest:

Workforce Innovation Reduces Medicaid Costs in Chronic Care

This study of community health workers as clinical extenders demonstrates significant cost savings in managing chronic conditions among Medicaid beneficiaries.



Rituparna Bhattacharya, PhD

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.



Cynthia Veronica Siego, MS

Latest:

The Value of Virtual Physical Therapy for Musculoskeletal Care

This counterfactual simulation study on a nationally representative sample of the working population with musculoskeletal conditions estimated the value of patient-initiated virtual physical therapy.


Keith E. Kocher, MD, MPH

Latest:

Development of Multipayer Claims-Based Emergency Department Episodes of Care

Thirty-day episodes of care initialized by emergency department visits can inform future quality improvement efforts.


Richard M. Grimes, PhD

Latest:

Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease

Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.


Tiffany Meng, PharmD, is an oncology pharmacists at UCSF Health.
Tiffany Meng, PharmD

Latest:

Ways to Mitigate Financial Toxicity for Patients With Breast Cancer

Tiffany Meng, PharmD, an oncology pharmacist, UCSF Health, discusses how pharmacists help mitigate financial toxicity for patients with breast cancer.




Yasin Civelek, PhD, MS

Latest:

Trends in Low-Value Cancer Care During the COVID-19 Pandemic

Among adults with newly diagnosed cancer, rates of low-value cancer services persisted throughout the COVID-19 pandemic in areas ranging from peridiagnosis imaging to end-of-life care.


Christopher Kirwan, PhD

Latest:

Addressing Virtual Care Disparities for Patients With Limited English Proficiency

With increased use of virtual care due to the COVID-19 pandemic, the following recommendations address disparities for patients with limited English proficiency.


Kimberley H. Geissler, PhD

Latest:

Clinician Characteristics Associated With Fluoride Varnish Applications During Well-Child Visits

Clinicians treating a higher percentage of patients insured by Medicaid and patients younger than 5 years were more likely to apply fluoride varnish.


Manxiang Li, PhD, MD

Latest:

Determinants of ICS Therapy Adherence in Patients With Asthma

This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China.


Adriana Olivo, NP

Latest:

Reassurance in Breast Cancer Survivorship: Adriana Olivo, NP

Survivorship care and patient tools like the breast cancer index help patients and doctors curate an individualized survivorship plan for each patient.


Stephen Roll, PhD

Latest:

Predictors of and Barriers to Receipt of Advance Premium Tax Credits

Few eligible individuals apply for the Advance Premium Tax Credit due to knowledge barriers. Additionally, specific sociodemographic characteristics appear to predict applying status.


Ellen Beckjord, PhD, MPH

Latest:

Integrated Care for Chronic Conditions: A Randomized Care Management Trial

The authors sought to understand the differential impact of payer-led community-based care management approaches on stakeholder-oriented outcomes for publicly insured adults with multiple chronic conditions.


Amy O. Flaster, MD, MBA

Latest:

Improving Care Coordination and Reducing ED Utilization Through Patient Navigation

A navigation program demonstrated decreased odds of repeat emergency department (ED) visits in patients with low baseline ED utilization and increased odds of follow-up primary care appointments.


Dhwani Mehta, MS

Latest:

Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action

No One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.


Brian Klepper, PhD

Latest:

Direct Contracting With Accountable Care Organizations: The Purchaser Perspective

This article provides insight into health care purchaser priorities and considerations for direct contracting opportunities, along with considerations for interested accountable care organizations.


Andrea L. Cherrington, MD, MPH

Latest:

Measuring Continuity of Care for Diabetes: Which Visits to Include?

This study examined how inclusion of different provider specialties affected Continuity of Care Index values, year-to-year stability, and association with emergency department visits.

© 2026 MJH Life Sciences
AJMC®
All rights reserved.